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Abstract
Topical vaginal anti-HIV microbicides are an important focus in female-based strategies to prevent the sexual
transmission of HIV. Understanding microbicide pharmacokinetics is essential to development, characterization and
implementation of efficacious microbicide drug delivery formulations. Current methods to measure drug
concentrations in tissue (e.g., LC-MS/MS, liquid chromatography coupled with tandem mass spectrometry) are highly
sensitive, but destructive and complex. This project explored the use of confocal Raman spectroscopy to detect
microbicide drugs and to measure their local concentrations in fluids, drug delivery gels, and tissues. We evaluated
three candidate microbicide drugs: tenofovir, Dapivirine and IQP-0528. Measurements were performed in freshly
excised porcine buccal tissue specimens, gel vehicles and fluids using two Horiba Raman microscopes, one of which
is confocal. Characteristic spectral peak calibrations for each drug were obtained using serial dilutions in the three
matrices. These specific Raman bands demonstrated strong linear concentration dependences in the matrices and
were characterized with respect to their unique vibrational signatures. At least one specific Raman feature was
identified for each drug as a marker band for detection in tissue. Sensitivity of detection was evaluated in the three
matrices. A specific peak was also identified for tenofovir diphosphate, the anti-HIV bioactive product of tenofovir
after phosphorylation in host cells. Z-scans of drug concentrations vs. depth in excised tissue specimens, incubated
under layers of tenofovir solution in a Transwell assay, showed decreasing concentration with depth from the surface
into the tissue. Time-dependent concentration profiles were obtained from tissue samples incubated in the Transwell
assay, for times ranging 30 minutes - 6 hours. Calibrations and measurements from tissue permeation studies for
tenofovir showed good correlation with gold standard LC-MS/MS data. These results demonstrate that confocal
Raman spectroscopy holds promise as a tool for practical, minimally invasive, label-free measurement of microbicide
drug concentrations in fluids, gels and tissues.
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Introduction
Currently, there are more than 34 million people living with
AIDS globally; in particular, women continue to be
disproportionately affected. In 2011, women accounted for
approximately 58% of individuals living with HIV/AIDS in Sub-
Saharan Africa [1]. Biological vulnerability, gender-based
violence, socio-economic inequalities, and inability to negotiate
safe-sex practices are key factors contributing to a higher HIV
prevalence in women. These issues stimulate a growing need
for women’s preventive strategies. In the continued absence of
an effective and approved anti-HIV vaccine, topically acting
microbicides have become a focus in female-based strategies
to prevent the transmission of HIV from infected male partners.
A successful microbicide formulation establishes drug
concentration distributions at target sites sufficient to remain
prophylactic against HIV over time of exposure. Current lead
delivery vehicles are vaginal gels [2] and rings [3]. After failures
of earlier gel products, vaginal application of a 1% Tenofovir
gel was shown to reduce the risk of HIV sexual transmission by
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39% [4] in one (CAPRISA 004) of two studies [5,6], and a third
Phase 3 trial (FACTS 001) is currently underway with this same
formulation [7]. Tenofovir exhibits anti-HIV activity by inhibiting
HIV DNA transcription after phosphorylation to Tenofovir
diphosphate in host cells [8]. Recently, Tenofovir, in
combination with Emtricitabine in an oral product termed
Truvada® (Gilead Sciences, Foster City, CA) was found to be
effective in reducing the risk of contracting HIV, and has gained
approval by the FDA for this indication [9].
Knowledge of microbicide drug pharmacokinetics (PK) and
its determinants is essential to understanding microbicide
functionality and to microbicide product development. Such
information can guide a rational design process in which the
product and its dosage regimen are optimized to achieve target
drug delivery, i.e. requisite drug concentrations in target
compartments over time of HIV exposure. In PK analysis of
vaginal microbicides, drug concentrations are typically
measured in cervicovaginal fluids, cervical and vaginal tissues
and blood plasma [10-15]. These biological matrices are
homogenized or mixed prior to measurement by analytical
techniques such as HPLC and LC-MS/MS [16,17]. Central to
this is the fidelity of sampling and measuring drug
concentrations. For vaginal and cervical mucosal tissues
(where the majority of contemporary microbicidal molecules
act) this is particularly challenging, for a number of reasons,
including:
1. Human vaginal mucosal tissue is obtained by punch
biopsies, and these are limited in number and not readily
standardized with respect to thickness of the excised tissue.
2. This tissue is homogenized, so that only weight-averaged
values of concentration are obtained. Thus, these weight
averages of concentration contain uncontrolled variability due
to the non-controlled thickness of the tissue specimens.
3. Gradients in drug concentrations down through the
epithelial and stromal layers have the consequence that
concentrations measured in biopsy tissue homogenates
overestimate the volume average values for the stromal layer
[18] where infection is believed to occur.
4. The analytical measurements of microbicide drugs require
sophisticated instrumentation and methodology. For example,
the contemporary technique to measure Tenofovir and
Tenofovir-diphosphate (its bioactive form) concentrations in
tissue involves LC-MS/MS (liquid chromatography separation
coupled with tandem mass spectrometry detection) in a highly-
sensitive but expensive and sophisticated methodology that is
not widely available.
During development and evaluation of candidate microbicide
formulations, in vivo PK studies are frequently complemented
by in vitro measurements of drug transport into and through
specimens of excised human and animal cervicovaginal tissues
[10,13]. After collection, these specimens are stored under a
number of conditions prior to their testing for drug permeation,
e.g. via snap freezing or immediate immersion in fixative and
culture media. Clearly, the properties of these harvested
tissues are not identical to those of the intact material in vivo.
For example, there is no active vasculature that can clear drug
in the lamina propria. The fine structure of the tissue may be
altered; e.g. as cells swell the intracellular clefts may be
reduced in size, and this could alter drug diffusion through the
tissue [19]. Such differences between harvested and in situ
tissue notwithstanding, there has been longstanding scientific
use of in vitro assays of tissue permeability to various
molecules, e.g. endogenous physiological modulators and
drugs [20-22]. In the microbicides field, such assays are used
to compare different vehicles as well as drugs themselves
[23-25]. Typically, the rate of drug transport is characterized in
terms of the permeability parameter. This is equal to the
product of the drug diffusion coefficient and its partition
coefficient (at the vehicle-tissue interface) divided by the
thickness of the tissue specimen. An experimental
configuration such as a Franz Cell is typically used in
measuring permeability. Here, a fluid or gel overlayer (called
the “donor compartment”) is placed over the tissue specimen
supported by a porous membrane. Drug is sampled from a
stirred “receiver compartment” beneath the membrane. The
drug permeability is obtained by monitoring its concentration in
the receiver compartment and assuming that it is a linear
function of time. Although permeability is a useful parameter in
understanding drug transport from a delivery vehicle into and
through a tissue specimen, it is not a fundamental material
property of the transport process. Rather, it is a derived
parameter that depends upon three basic parameters: the
diffusion coefficient for drug transport through the tissue; the
partition coefficient at the vehicle-tissue interface; and the
thickness of the tissue specimen. Strictly speaking, the
deduced permeability also depends upon the resistance to
drug transport of the porous membrane that supports the
tissue, but this is usually neglected. Published data on
permeability of Tenofovir through excised human cervical
vaginal tissue specimens have shown considerable inter- and
intra-patient variability [10]. The reasons likely relate to natural
biological variability in the tissues and also technical variability
in the performance of the permeability assay.
Clearly, there is a need for improved methodology that can
sample local drug concentrations, e.g. in relation to depth, in
specimens of mucosal tissue. This would improve our
understanding of drug concentrations in biopsy specimens
taken in PK studies and their interpretation with respect to
anticipated prophylactic concentrations. It would also improve
our understanding of the mechanisms of the drug transport
process overall, which could translate into improved product
design. For example, information on drug concentration
distributions in tissue, with respect to depth and time, could be
used to deduce the diffusion coefficient within that tissue (and
compartments within it, viz. the epithelium and stroma). This
parameter is the salient measure of the rate of drug transport,
and is a critical input to mechanistic models of such transport
[18]. A practical, user-friendly, and minimally invasive method
for performing such measurements would thus benefit our
understanding of the performance of microbicide formulations
and be valuable in other contexts of drug delivery, as well.
An attractive approach to performing local drug concentration
measurements is the use of Raman spectroscopy. This is an
analytical technique that can be used to optically probe and
quantify specific molecular components in heterogeneous and
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highly scattering matrices, such as tissues, in real time [26].
The Raman technique requires minimal sample processing and
has been shown to be of practical value for measuring target
molecular concentrations in a variety of biological matrices as
well as in drug delivery vehicles [27,28]. Theoretically, when
monochromatic radiation interacts with a compound, light may
be absorbed or scattered. The majority of the scattered light
undergoes elastic Rayleigh scattering, such that the scattered
photon has the same energy content and wavelength as the
incident photon. A small fraction of light (around 1 in 107
photons), however, is inelastically scattered at a different
wavelength to the incident light in a process called Raman
scattering. The rotational and vibrational states of a molecule
reveal the pattern of shifted frequencies, called Raman shifts,
which are characteristic of the nature of specific chemical
bonds present in the molecule. This renders Raman
spectroscopy highly chemically specific, such that it can
provide structural and chemical fingerprint information unique
to the molecule.
Over the past decade, Raman spectroscopy has become
widely investigated for biomedical applications since it can
reveal the chemical fingerprints of different target molecules,
cells and tissues [29,30]. It is increasingly employed to detect
target molecules in skin and tissues in vitro and has been
applied to evaluate the composition of human skin (e.g., cancer
diagnosis) in vivo. It is particularly useful for real-time diagnosis
of diseases that alter the subcellular components of the
tissues. Applications of Raman spectroscopy for detection of
cancers of the breast, lung, skin and bladder, as well as
vulnerable plaque in atherosclerosis have been documented
[29]. Moreover, confocal Raman spectroscopy (CRS) has been
utilized to examine the penetration and delivery of drugs into
human skin in vitro and in vivo [31,32], and to assess
biomolecular compositions and hydration of human skin [33].
These findings demonstrate the promising capacity of CRS as
a rapid and noninvasive approach to track drug permeation in
real time across tissues. Recently, a combined CRS and time
domain optical coherence tomography (TD-OCT) system has
been developed to measure depth-resolved Raman signals
from tissue samples imaged by the OCT [34]. This technique
integrates the depth-sensitive biomolecular specificity of CRS
with the morphological analysis capability of OCT to provide
noninvasive characterization of biological tissues. An example
was cited for measurements on a “goat mucous membrane
having an epithelial layer on top of a relatively thicker stromal
layer.”
Although the Raman spectroscopic technique has been
extensively used in various biomedical applications, its
implementation in the microbicides field has yet to be fully
explored; to date, there has been only a single published
paper. Bell et al. used Raman spectroscopy to detect
Dapivirine in silicone elastomer intravaginal rings (IVR),
mapping the drug distribution in both the sheath and core of the
devices [35]. This information was useful in understanding the
loading and rate of drug release from the rings.
The present study aimed to investigate the feasibility of using
confocal Raman spectroscopy to detect microbicide drugs and
to measure their local (i.e. position dependent) concentration
distributions within fluids, gel vehicles, and tissue specimens.
The study was an initial, technical evaluation of the application
of this promising methodology 3 candidate microbicide drugs
were evaluated: Tenofovir, Dapivirine and IQP-0528. All of
these are being formulated and evaluated in vaginal gels and
rings [13,36-38]. As noted above, there have been a number of
Phase 3 trials of a vaginal gel that contains 1% Tenofovir.
There are now two Phase 3 trials of an intravaginal ring loaded
with Dapivirine [39,40]. IQP-0528 is a candidate microbicide
drug in earlier stages of development [13,41]. Our analyses
demonstrated the capabilities of Raman spectroscopy to
identify all three of these drugs in tissue specimens. In so
doing, we employed procedures used previously by other
investigators for preparations of the drugs in media and their
applications to excised tissues. As noted above, our in vitro
manipulations of tissue exposure to drugs in different media, as
those of our colleagues in other in vitro studies, likely altered
tissue microstructure to some extent and, consequently, drug
diffusion therein. Consistent with these companion studies, we
did implement an assay of tissue cell viability, the MTT assay.
Our goal was, thus, to conform to the standard of practice in
the microbicides field while investigating a new analytical tool
for application within that field. Such application could be for
analyses of drug distributions within tissues that had been
dosed with drug in vivo prior to collection (viz. PK studies), and
for in vitro applications of drug to harvested tissue. We
emphasized Tenofovir, and its gel formulation that has and
continues to be tested in clinical trials. More is known about
this drug than other microbicide compounds under evaluation.
Tenofovir is the drug that has advanced the furthest towards
demonstration of topically acting anti-HIV efficacy and
regulatory approval of its gel as a topical anti-HIV product.
Thus, for technical demonstration of the many of the features of
applying Raman spectroscopy to microbicides, we focused
primarily upon this drug. In so doing, we analyzed the clinical
Tenofovir gel currently in a third Phase 3 trial, and also the gel
used in the trials as a control for the Tenofovir gel. Both the
Tenofovir and placebo gels are based on
hydroxyethylcellulose. However there are differences in their
compositions and, thence, in properties such as pH values. As
such, these are not physicochemically matched gels, the
control gel simply being devoid of the active pharmaceutical
ingredient. However, such differences do not confound the
context of our results, which are focused on the feasibility of
using confocal Raman spectroscopy for these types of drug
concentration measurements.
Our study proceeded in several stages.
• We evaluated the Raman spectra of the three drugs in
solution. Here, we also included evaluation of the spectrum of
Tenofovir Disphophate, which is the bioactive form of Tenofovir
that is created by phosphorylation after it enters cells (see
below).
• We incubated specimens of porcine buccal tissue with
these drug-laden solutions, after which we obtained the Raman
spectra in the tissue and identified spectral peaks unique to the
drugs that were distinct from those of the tissue. In so doing,
we monitored the viability of the tissue specimens that had
been incubated with Tenofovir gel over time. This provided
Confocal Raman Spectroscopy of Microbicides
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initial proof of principle that Raman can be used to detect the
drugs in tissue.
• We incubated the Tenofovir clinical gel with tissue
specimens and again identified Raman spectral peaks in the
tissue that can be used to detect this drug. Here, the Raman
spectrum in tissue was different from that after incubation with
solutions; that is, gel components (primarily glycerol) had
entered the tissue and altered its Raman signature vs. that
after incubation with Tenofovir-laden solution. As a gel control,
we also incubated tissue specimens with a
hydroxyethylcellulose gel, devoid of glycerol, that is used as a
placebo in current microbicide gel trials.
• We evaluated the linearity of the drug-specific Raman
spectral peaks in tissue vs. drug concentration. Serial dilutions
of drugs in solution were performed. Drugs were also incubated
to equilibrium after thorough mixing into homogenized tissue
specimens. Linearity of the relationships of Raman signature
peak heights vs. drug concentrations was assessed, and
measurement sensitivities and limits of detection were
obtained. In these experiments, we also measured Tenofovir
concentrations in the tissue specimens by a gold-standard
validated method of liquid chromatography coupled to mass
spectrometry (LC-MS/MS). Drug concentration measurements
by LC-MS/MS were compared to those obtained from Raman,
as a means to validate the Raman spectral approach to drug
concentration measurements in tissue.
• We then began analysis of the application of Raman to
measure the varying local concentrations of Tenofovir as it
permeates into and through whole tissue specimens. A
Transwell configuration was created in which a drug-laden fluid
layer was placed over a specimen of excised tissue. This
enabled drug to permeate out of the fluid, and into and down
through a tissue specimen. At specified times after the onset of
fluid-tissue contact, depth-specific Raman spectra were
obtained (“z-scans”) using a confocal Raman microscope.
Thence, the relationship of Tenofovir concentration vs.
horizontal position (depth) in the tissue was evaluated.
Collectively, these different experiments provided evidence
that Raman spectroscopy, in particular as applied confocally, is
a promising methodology for measuring microbicide drug




This study used freshly excised porcine buccal tissues. The
tissues were obtained with permission from a local abattoir
(Hatley Family Farm, Hurdle Mills, NC).
Porcine Buccal Tissue Preparation
In our study, specimens of freshly excised porcine buccal
tissue were used for in vitro analysis of drug transport into and
through tissue. This material was used here as an in vitro
substitute for human vaginal mucosa, owing to its relative
abundance and structural similarity to human buccal mucosa,
which is in turn histologically comparable to the vaginal mucosa
[42-44]. Studies have shown that porcine buccal mucosa is
less permeable to test molecules than human vaginal mucosa
[45,46], and thus use of excised porcine buccal tissue provides
a conservative estimate of drug permeation through human
vaginal mucosal tissue. Although quantitative results for drug
transport in the porcine tissue may not equate to those in
human tissue, the material is structurally relevant for evaluation
of the suitability of the Raman approach for measurements of
drug concentration profiles. A high level of optical similarity
between Raman spectra of human tissue and porcine tissue
has been demonstrated [47-49].
Fresh porcine buccal tissue was harvested from domestic
medium-sized pigs’ heads obtained from a local abattoir
(Hatley Family Farm, Hurdle Mills, NC) immediately after
slaughter. The tissue was transferred to the laboratory in ice-
cold isotonic, aerated (5% CO2 and 95% O2) Krebs-Henseleit
buffer (pH 7.4; Sigma cat. # K3753: 1.2 mM MgSO4, 1.2 mM
KH2PO4, 4.7 mM KCl, 118 mM NaCl ), supplemented with 2.5
mM CaCl2, 25 mM NaHCO3, 4 mM HEPES, and 12.2 mM
glucose. The buffer composition was modified to be closer to
previously published formulations of the storage buffer for
porcine buccal tissue [50,51]. The concentration of potassium
ion exceeds physiologic conditions, and this buffer formulation
may cause cell swelling which would reduce the intra-cellular
spaces and slow diffusion of drugs within that space. To
prepare tissue specimens, within 1 h postmortem the
underlying connective tissue and fat were removed with a
scalpel blade and surgical scissors. The mucosa was sliced
with a Thomas Stadie-Riggs tissue slicer (Thomas Scientific,
Swedesboro, NJ) to obtain consistent tissue thicknesses.
Unless otherwise noted, skin biopsy punch devices (Acuderm,
Fort Lauderdale, Florida) were used to cut freshly excised
tissue slices into circular specimens (7-mm diameter; 1-mm
thickness). The thicknesses of the tissue slices were measured
with a micrometer to achieve the target thickness and minimize
variations among them. To prepare tissue homogenates, the
tissue was processed with an Omni General Laboratory
Homogenizer for 5-10 minutes at a speed of 25000 rpm. No
extra fluid was added.
Evaluation of the Viability of the Porcine Tissue
Specimens
The viability of tissue specimens used in our protocol was
assessed by the reduction of the tetrazolium salt 1-(4,5-
dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT; Sigma) by
viable cells into formazan (a dark purple water insoluble
compound). The MTT assay is a well-established viability and
cytotoxicity assay [52,53] that measures cellular metabolic
activity in tissue [54]. It is commonly used in the microbicides
field to evaluate tissue specimen viability [10,23,24]. MTT is
reduced to a formazan dye by the succinate-tetrazolium
reductase (TR) system of the mitochondrial respiratory chain,
which is active only in living cells [52,55]. Thus, the quantity of
the dye produced directly correlates to the number of
metabolically active, viable cells. Results are typically
presented as a ratio of the optical density of the formazan
product at 570 nm to the dry weight of the tissue specimen (TR
index).
Confocal Raman Spectroscopy of Microbicides
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Freshly excised tissue specimens (7-mm diameter; 1-mm
thickness; n=3) were incubated while fully submerged in 1%
Tenofovir clinical gel and maintained at 5% CO2 and 37 °C for
different amounts of time (2, 6, 9, and 24 h) in a Heracell
incubator (Thermo Scientific, Asheville, NC). Each time point
was carried out in triplicate. After incubation, each tissue
specimen was removed from the gel, washed five times with
PBS (Invitrogen, Grand Island, NY) and transferred to a 48-well
plate (Corning Incorporated, Corning, NY) for the MTT viability
assay. 1 mL of MTT solution (0.5 mg/ml in Krebs buffer) was
added to each well and incubated with the tissue specimen for
3 h at 5% CO2 and 37 °C. After 3 h, the tissue specimen was
removed from the MTT solution and rinsed five times with PBS.
The formazan product was extracted from the tissue by
submerging the tissue sample overnight in 4 ml isopropanol on
a rotating platform. The optical density of formazan was
measured at 570 nm with isopropanol as a blank (Shimadzu
UV1800 spectrophotometer). The tissue samples were dried
overnight in a lyophilizer and then weighed. The TR index was
then computed. The first viability assay (control) was
conducted on fresh untreated tissue specimens and began 1.6
h post mortem (quickest possible time). In addition, the viability
assay was implemented on deactivated tissue specimens as a
control; these were boiled in water for 2h to inactivate enzyme
activity prior to the assay.
Spectral Raman Measurements
Measurements were performed on two Raman microscope
systems: a Horiba LabRAM ARAMIS Raman Microscope and a
Horiba Xplora confocal Raman microscope (Horiba Jobin
Yvon). Initial studies were performed with the former. The latter
was then used in a Transwell assay (see below) to measure
Tenofovir concentrations vs. depth in excised tissue
specimens. Two external excitation sources were used with the
Horiba LabRAM ARAMIS: a 785 nm NIR diode laser (Pilot
series, Sacher Lasertechnik, Marburg, Deutschland) and a 633
nm He-Ne laser (Melles Griot, Carlsbad, CA), delivering
approximately 20 mW and 5 mW at the sample level,
respectively. The Horiba Xplora microscope employed an
integrated internal laser of 785 nm, delivering a power of
approximately 25-30 mW. NIR excitation was used with tissue
because tissue autofluorescence and absorption of light by
tissue is low in the NIR domain, thereby increasing depth of
photon penetration in tissue and minimizing the effect of tissue
heating. The spectrograph has an air-cooled CCD detector
(Synapse, Horiba Jobin Yvon) and gratings of 600, 1200, 1800,
and 2400 gr./mm. The objective lenses used in the study were
50x long-working distance (Long Working Distance M Plan
Semi-Apochromat, LMPLFL50x, Olympus) and 10x (M Plan
Achromat, MPLN10x, Olympus), operating in air, with
numerical apertures of 0.5 and 0.25, respectively. The focal
spot size of sampling at the tissue surface was measured to be
approximately 18 x 10 and 72 x 76 µm2 for the 50x long-
working distance and 10x objectives, respectively. The analysis
of bulk fluids was performed with the 10x lens. The 50x lens
was used to obtain the confocal depth-scanning
measurements. An automated XYZ sample stage was moved
axially to obtain z-scans of spectra vs. depth into a specimen.
The approximate depth of focus was derived from the Full
Width at Half Maximum (FWHM) of the axial intensity response
curve of the silicon band at 520 cm-1. Depth of focus is affected
by the optical properties of the material surrounding the object
of interest. We measured depth of focus of the 50x lens on a
polished silicon wafer in air (non-scattering medium), and when
the wafer was covered by 240 μm of scattering tissue phantom
(1% Intralipid and 2% Agar) for three different confocal pinhole
sizes (Table 1). Spectral acquisition was obtained using
LabSpec software (Horiba Scientific, Edison, New Jersey).
Spectra were averaged from two to five accumulations, each
with an acquisition time ranging from 15 s to 5 m. The
conditions of measurement were adjusted depending on the
type of the matrix to obtain a good signal-to-noise ratio without
damaging the tissue samples during the period of
measurement. The laser beam was directed onto the surface of
each tissue specimen with a quartz cover slip (Esco Optics
Inc., Oak Ridge, New Jersey), which was used to flatten the
sample surface and prevent tissue dehydration.
Data Processing
Recording and processing of spectral images were
performed using LabSpec software (Horiba Scientific, Edison,
New Jersey). Acquired Raman spectra were smoothed using
Savitzky-Golay smoothing, and baseline-subtracted by line-
segment baseline subtraction. The curve fitting procedure was
based on a nonlinear least-squares method to a Gaussian
distribution, accounting for random noise in the measured
spectra and determining peak positions and intensities. These
spectral data were then exported to MATLAB (MathWorks,
Natick, MA) for further analyses.
Statistical analysis was performed using statistical software
Statview 5.0 (SAS Institute Inc., Cary, NC). P values less than
0.05 were considered indicative of statistical significance.
Table 1. Depth of focus (μm) of the Horiba confocal Raman microscope when using a 50x objective lens measured on a
polished silicon wafer, comparing the wafer in air versus the wafer covered by a scattering tissue phantom layer of 240 μm.
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Spectral Raman Signatures of Microbicide Drugs
Three microbicide drugs were evaluated: Tenofovir,
Dapivirine, and IQP-0528. Tenofovir powder (Lot No.: 1278-
H-1), Tenofovir clinical gel (MTN-003, Sublot Code: 581), and
HEC clinical placebo gel (MTN-003, Sublot Code: 990) were
generously provided by the CONRAD Program (Arlington, VA).
Compositions of these gels are shown in Table 2. Both gels
were formulated at a pH of 4 to 5 to mimic the normal vaginal
pH [56]. The Tenofovir gel was designed by CONRAD to have
a small amount of acidic buffer. The HEC placebo gel,
however, was designed with no buffer. Their intent was that the
placebo would not perturb the normal vaginal pH, but also be
non-reactive when a study subject had sex and alkaline
seminal plasma was introduced [57]. Dapivirine powder (Lot
No.: 60416PIL03) and Dapivirine clinical gel (Batch No.:
09M02) were kindly supplied by the International Partnership
for Microbicides (Silver Spring, MD). IQP-0528 powder (Lot
No.: SJV-090224) and IQP-0528 clinical gel (Lot No.:
WL121108) were generously provided by Imquest Biosciences
(Frederick, MD). Serial dilutions in solutions, gels, and
homogenized tissues were performed to identify spectral peaks
of the drugs. Serial dilutions of Tenofovir, ranging from 0.01 to
1 %w/w, were prepared in alkalinized water, gel, and porcine
buccal tissue homogenates. The alkalinized water (50 mM
NaOH) was made by alkalinizing the High Performance Liquid
Chromatography (HPLC) grade water (EMD chemicals,
Darmstadt, Germany) with 5M NaOH stock solution (Sigma
Aldrich, St. Louis, MO). Serial dilutions of Dapivirine, ranging
from 0.003 to 0.05 %w/w, were prepared in 30:70 (v/v) water/
isopropyl alcohol (Sigma Aldrich, St. Louis, MO) mixtures, in
gels, and porcine buccal tissue homogenates. Serial dilutions
of IQP-0528, ranging from 0.01 to 0.5 % w/w, were prepared in
HPLC grade ethanol (>99.8%, Sigma Aldrich, St. Louis, MO),
gels, and porcine buccal tissue homogenates.
Additionally, a stock solution (84.5 mM) of Tenofovir
diphosphate in water (pH 7.4) was generously provided by
Gilead Sciences (Foster City, CA). The solution was diluted to
a working concentration of 4.08 mM (0.18 %w/w). The Raman
spectrum of Tenofovir diphosphate solution in water was
obtained for comparison with the spectra of Tenofovir in water
and with the water control.
Before taking measurements, 120 µl samples of drugs (in
either solutions, gels, or porcine buccal tissue homogenates)
were loaded into each well of a 384-well, quartz bottom plate
(Matrical Bioscience, Spokane, WA). The sample surfaces
were flattened to allow maximum beam exposure and avoid
interferences generated from surface roughness scattering.
Raman Spectra in Tissue Specimens
Fresh porcine buccal tissue specimens (7-mm diameter, 1-
mm thickness) were incubated in either 1% Tenofovir clinical
gel or HEC placebo clinical gel for 6 h in a Heracell incubator
maintained at 37°C and 5% CO2. The Raman spectra were
recorded to demonstrate the spectral peaks unique to
Tenofovir that were distinct from those of the gel and tissue.
Comparative Measurement of Tenofovir Concentration
using Raman and LC-MS/MS
Fresh porcine buccal tissue specimens (4mm x 4mm x 3mm)
were immersed in isotonic Ringer’s solutions (Hospira Inc.,
Lake Forest, IL) containing different concentrations of Tenofovir
(0.01, 0.03, 0.1, 0.3, 1 % w/w) and allowed to equilibrate for 24
h at 4°C. After 24 h, the tissue specimens and the surrounding
fluid were collected separately and stored at −80°C overnight
for further analysis. The final concentrations of Tenofovir in the
surrounding fluid and in tissue were measured by Raman and
LC-MS/MS. In order to measure concentrations in fluid using
the Raman spectroscopic technique, residual fragments of
tissue in final fluid samples were removed through
centrifugation (twice at 12000 rpm for 10 minutes) using the
Eppendorf 5417 C microcentrifuge. The supernatants were
then collected for analysis.
To obtain quantitative analysis using LC-MS/MS [58], tissue
samples were placed in tubes with water (10:1 v:w) and
homogenized using a bead beating method developed on a
Precellys® system prior to centrifugation to obtain an extract.
Table 2. Compositions of clinical 1% Tenofovir gel and HEC placebo gel.
Gel Ingredient
1% Tenofovir Tenofovir (1% w/w)
 Edetate disodium
 Citric acid
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The resulting tissue extracts or incubation solution containing
Tenofovir were further diluted with water and mixed with
isotopically-labeled Tenofovir (Tenofovir-IS) as an internal
standard. Analytes were retained on a Waters Xbridge C18
(2.1 X 20 mm, 5μm) analytical column and eluted under
gradient conditions. Data were collected on an Agilent® 6410
triple quadrupole mass spectrometer, using Agilent LC-MS/MS
MassHunter Chromatography Software, using electrospray
ionization with positive ion m/z transitions of 288/176
(Tenofovir) and 293/181 (Tenofovir-IS). Peak area ratios of
Tenofovir to Tenofovir-IS were used for quantitative analysis.
Transwell Assay
A Transwell assay was designed as a standard procedure to
quantify time and depth-dependent drug concentration profiles
in tissue (cf. Figure 1). The configuration had a reservoir of an
isotonic solution of 1% Tenofovir in PBS on top of an excised
porcine buccal tissue specimen (7-mm diameter, 1-mm
thickness), under which was a bath of isotonic PBS to hydrate
the tissue sample.
For a given experiment, tissue samples were first fitted into a
24-well Transwell plate having an 8.0 µm pore-size
polycarbonate membrane (Cat. No. 3422, Corning
Incorporated, Corning, NY). Next, Matrigel (BD Biosciences,
San Jose, CA) was applied around the edges of the tissue
samples to minimize seepage along the samples’ sides. Timing
of the experiment began when the Tenofovir solution was
applied to the top of the tissue. PBS was underneath the
polycarbonate membrane for the duration of the experiment.
The Transwell setup was maintained at 37°C and 5% CO2 in a
Heracell incubator for varying times, ranging from 30 min to 24
h. Once the desired incubation times were reached, the tissues
and fluids were isolated and stored in a −80°C freezer
overnight to stop the drug permeation process. Thawed tissue
specimens were then subjected to confocal Raman scans at
different depths from the surface down into the tissue proper
(z-scans). Thawed fluids were also scanned. Quantification of
Tenofovir concentrations was performed by interpolation,
referencing to calibration curves of drug in tissue homogenates
and fluids from the measurements described above.
Results
Spectral Raman Signatures of Microbicide Drugs
The first part of our study involved identifying characteristic
Raman features unique to Tenofovir, IQP-0528, and Dapivirine.
Figure 2 and Table 3 show spectral Raman signatures of
Tenofovir along with vibrational assignments specific to these
bands. Raman spectra of Tenofovir and Tenofovir diphosphate
consist mainly of two sets of lines: ring vibrations of the
adenine moiety and characteristic vibrations of the phosphate
modes. Most of the strong vibrational features of Tenofovir are
due to the adenine moiety with the strongest band located at
725 cm-1, while the phosphate group only contributes to weak
vibrations. Tenofovir diphosphate, however, shows a prominent
phosphodiester peak at 1112 cm-1 due to the symmetrical
stretching vibrations of the PO2ˉ combinations. Since this peak
is absent in Tenofovir, it renders the spectra of Tenofovir and
its diphosphate form distinguishable spectrally.
In addition to those for Tenofovir, we found characteristic
Raman bands for IQP-0528 and Dapivirine (Table 4). The
strongest Raman features of IQP-0528, located at 1676 cm-1
and 549 cm-1, are due to the C=O stretching and in-plane
bending modes of the uracil (thymine) moiety, respectively.
Another strong Raman spectral feature of IQP-0528 was found
at 1595 cm-1 as a result of the aromatic ring stretching vibration
of the 1,3-dimethylbenzene ring moiety. Most of the strong
vibrational features of Dapivirine are due to the benzonitrile
Figure 1.  Schematic of Transwell assay for measuring Tenofovir transport into and through an excised tissue
specimen.  Circular porcine buccal tissue specimens were maintained in Transwell supports, under which was a bath of PBS to
hydrate the tissue. Matrigel was used to create a gelatinous seal around tissue edges to prevent leakage. An isotonic solution of 1%
Tenofovir in PBS was applied to the apical surface. The assay was maintained at 37°C and 5% CO2 in a Heracell incubator for 30
min to 6 h.
doi: 10.1371/journal.pone.0085124.g001
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moiety, while the mesitylene ring occurs as medium-to-weak
Raman bands.
For a microbicide drug to be detectable in a practical,
biologically relevant context, its Raman features must be
sufficiently free from interference from solvent and tissue
bands. Comparisons of the microbicide spectra and the tissue
spectra enabled us to select the specific Raman bands that
were strong and distinct from peaks due to the gel and tissue.
These characteristic Raman features can be used as markers
for detection of the microbicide drugs in tissue specimens that
have been exposed to microbicide gels. They are located at
725 cm-1 for Tenofovir, at 1112 cm-1 for Tenofovir diphosphate,
at 549 and 1595 cm-1 for IQP-0528, and at 1610 and 2223 cm-1
for Dapivirine. Details of all the Raman peaks and their putative
relationships to vibrational modes are given in Table 4.
Raman Spectra of Tenofovir in Tissue Specimens
Figure 3 shows the Raman spectra of excised porcine buccal
tissue specimens that were incubated while fully submerged in
1% Tenofovir gel or Placebo gel for 6 h. The most prominent
spectral feature of Tenofovir, at 725 cm-1, was used as the
marker to detect the drug in tissue. The signature peak of
Tenofovir was clearly distinct from peaks due to glycerol in the
test gel and tissue constituents. This Tenofovir gel contains
glycerol (20%), as can be seen by strong Raman features at
825 and 852 cm-1 due to the C-C stretching vibration of
glycerol. Although the Raman intensity of Tenofovir is weaker
than the glycerol signal, the vibration of Tenofovir is present in
the region where glycerol does not scatter strongly, enabling a
clear distinction between the Tenofovir and the glycerol.
Spectral Concentration Dependence and Measurement
Sensitivity
Successful Raman spectroscopic identification and
quantification of a target analyte in a matrix derives from
several interacting factors: (1) the analyte must exhibit
spectroscopic peaks distinct from those of the matrix material;
(2) the quantum efficiency of such peaks, which is driven by the
excitation light intensity, must elicit a response that, when
captured by the return optics, causes a signal which is
sufficiently larger than the noise level of the detector; and (3)
within the focal volume of the optical system, the Raman
emission (peak height) must increase sufficiently in relation to
analyte concentration. Tradeoffs amongst these factors are
Figure 2.  Raman spectrum of 1%w/w Tenofovir in water.  1% Tenofovir solution was prepared in alkalinized water (50 mM
NaOH). The Raman spectrum of the Tenofovir solution was acquired using a Horiba LabRam ARAMIS Raman microscope with an
excitation wavelength of 633 nm, 100μm slit width and a 10x objective lens. The acquisition time was 60s with 3 accumulations.
Data were normalized to the area under the curve.
doi: 10.1371/journal.pone.0085124.g002
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used to create several measures of the fidelity, or “sensitivity”
of the measurements [59]. The signal-to-noise ratio (from factor
(2)) establishes the limit of detection. The slope of the line of
Raman peak height vs. concentration (factor (3)) gives the
Table 3. Identification of Raman peaks vs. vibrational modes for Tenofovir.
Raman Shift ( cm-1 ) Tentative Assignment References
537 (w)a δ(C-C=C)b [74]
614 (vw) δ(N-C-C) [74]
725 (vs) Adenine ring breathing (in-phase stretching) [74,75]
802 (vw) ν(C-C) [74]
841 (w) β(skel) [74]
876 (vw) γ,δ(N-H) [74]
905 (vw) r(NH2) [74]
942 (vw) δ(N-C=N) [74]
973 (w) Phosphate [76]
1007 (w) Phosphate [76]
1255 (mw) ν(C-NH2); ν(C=N); ν(C-N); δ(C-H) [74,75]
1311 (ms) ν(C-N); ν(C=N); δ(C-H) [74-76]
1335 (s) ν(C-N); ν(C=N); w(CH2) [74,77]
1370 (ms) δ(C-H); γ,δ(C-H) [74]
1423 (w) δ(N=CH); w(CH3) [74,77]
1486 (w) δ(NH2) [74]
1517 (m) δ(C-N-H); Imidazole ring [74,75]
1581 (mw) ε(NH2) [77]
a vs, very strong; s, strong; ms, medium-strong; m, medium; mw, medium-weak; w, weak; vw, very weak.
b δ, bending; ν, stretching; r, rocking; w, wagging; ε, scissoring; β, in-plane; γ, out-of-plane; skel, skeleton vibration
doi: 10.1371/journal.pone.0085124.t003
Table 4. Salient Raman spectral peaks of microbicide drugs.
Drugs Raman peak (cm-1) a Tentative assignmentb References
Tenofovir 725 (vs)c Adenine, in-phase stretching [74,75]
 1112 (s)d Phosphate, νs(O−
⃛ P−⃛ O) [75,76]
 1311 (ms) Adenine, ν(C-N), ν(C=N) [74,75]
 1335 (s) Adenine/ w(CH2) [74,77]
 1370 (m) Adenine, β,γ(C-H) [74]
 1517 (m) Imidazole ring, β(C-N-H) [74,75]
IQP-0528 549 (vs) Uracil,β(C=O) [78,79]
 569 (m) Uracil, β(C=O) [78,79]
 670 (mw) Uracil, γ(N-H) [79]
 1009 (s) Uracil, ν(ring) [74]
 1299 (m) Uracil, ν(ring) [74]
 1595 (vs) Aromatic ring, ν(C-C) [80]
 1676 (s) Uracil, ν(C=O) [78]
Dapivirine 578 (m) Mesitylene, β(arene) [81]
 820 (mw) Mesitylene, γ(C-H) [81]
 980 (s) Benzonitrile, ν(C-C) [82]
 1174 (vs) Benzonitrile, β(C-H) [82]
 1610 (s) Benzonitrile, ν(C-C) [82]
 2223 (ms) Benzonitrile, ν(C≡N) [82]
a vs, very strong; s, strong; ms, medium-strong; m, medium; mw, medium-weak; w, weak; vw, very weak.
b β, in-plane bending; γ, out-of-plane bending; ν, stretching; r, rocking; w, wagging; s, symmetric; as, anti-symmetric
c Underlined peaks are markers identified for microbicide detection in tissue.
d Absent in Tenofovir
doi: 10.1371/journal.pone.0085124.t004
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“calibration sensitivity.” These factors are all influenced by the
optics of the system, scattering and absorption of light by the
matrix, and possible reactions of the matrix with the analyte of
interest. The “analytical sensitivity” is defined as the ratio of the
calibration sensitivity to the standard deviation of the signals in
a series of replicate experiments, and is a measure of the
accuracy with which an unknown amount of chemical can be
quantified. It can be improved by increasing the numbers of
replicates, but is governed by the all three factors listed above.
We found a strong linear dilution response (R2 ≥ 0.99) for
concentrations of Tenofovir, Dapivirine and IQP-0528 in the
three matrices—solutions, clinical gels, and tissue
homogenates. The measured Raman intensity was linearly
proportional to the concentrations of the active species. Figure
4 illustrates the linear response, showing the lines of Raman
signal vs. concentration for Tenofovir in fluid, clinical gel and
tissue homogenate. Figure 5 shows values of the calibration
sensitivity for the 3 drugs in fluid, gel and tissue homogenate.
Triplicate experiments were performed, in which standard
errors were relatively low. However, we defer quantitative
analysis of analytical sensitivity of this methodology to more
extensive replicate testing in the future.
Differences were found in Raman signal for three drugs in
different matrices. Using two-way ANOVA (drug and matrix as
main effects) with Fisher’s PLSD post hoc analysis, statistical
significances of these differences were examined. There was a
significant difference in calibration sensitivity amongst the
drugs (P<0.0001) and amongst the matrices (P<0.0001). In
addition, the relative calibration sensitivities in detecting the
drugs depended on the matrix within which they were
measured (for the drug X matrix interaction, P <0.01).
Generally, the calibration sensitivities were higher in fluids than
in the other types of media due to less background scattering
(because the fluids are transparent). In solution, the calibration
sensitivity in measuring Dapivirine was significantly higher than
that for IQP-0528 (P<0.0001), which had significantly greater
calibration sensitivity than that for Tenofovir (P<0.01). In tissue,
Dapivirine had significantly higher calibration sensitivity than
IQP-0528 (P<0.05), which had numerically greater sensitivity
than Tenofovir, although not quite at the level of statistical
significance (P=0.057) at this sample size. In gel, Dapivirine
had significantly higher calibration sensitivity than Tenofovir
and IQP-0528 (P<0.05), for which the calibration sensitivities
were not significantly different. Here, we note that the Tenofovir
clinical gel is transparent; in contrast, the other two clinical gels
are opaque due to light scattering, and this may have
contributed to the differential sensitivities across the gels.
Figure 3.  Raman spectra for clinical 1% Tenofovir (TFV) gel.  Fresh porcine buccal tissue specimens (7-mm diameter, 1-mm
thickness) were incubated by fully submerging them in 1% Tenofovir test gel (solid line) and HEC placebo gel (dotted line) for 6 h at
37°C and 5% CO2 in a Heracell incubator. The recorded Raman spectra demonstrated that the Tenofovir band was clearly
distinguishable from Raman peaks due to the gel and tissue. β, bending; ν, stretching ; τ, twisting; r, rocking.
doi: 10.1371/journal.pone.0085124.g003
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Overall, the calibration sensitivity in detecting Dapivirine was
greater than those for the other two microbicide drugs. This can
be explained by the effect of the Raman cross section of the
molecules. Compared to the other two drugs, the chemical
structure of Dapivirine (Figure 6) is less polar at rest. An
incident photon causes a greater change in polarization and
hence, gives relatively greater changes in Raman signal
intensity per change in its concentration. Thus, Dapivirine has
the highest sensitivity of detection. Tenofovir, however, is the
most polar compound at rest; therefore, it has the weakest
Raman intensity.
To determine the lowest concentrations of the microbicide
drugs that can be detected with acceptable reliability using the
Horiba LabRam ARAMIS system, we performed an analysis of
the limits of detection based upon the variability of values in
blanks (i.e., zero concentration standards). The limits of
detection were computed as mean blank value (n=7) plus three
times the standard deviation (Table 5). These were found to be
0.01%w/w, 0.02% and 0.04% for Tenofovir detection in water,
gel, and tissue, respectively. The limits of detection of
IQP-0528 at 549 cm-1were found to be approximately 0.01%
and 0.03% in ethanol and gel, respectively. The limit of
detection of IQP-0528 at 1595 cm-1 was found to be around
0.04% in tissue. In addition, the limits of detection of Dapivirine
at 2223 cm-1 were found to be approximately 0.003%, 0.006%,
and 0.006% in isopropanol/water mixture, gel, and tissue,
respectively.
Viability of Excised Tissue Specimens
The viability assay was conducted on tissue specimens that
had been incubated while fully submerged in 1% Tenofovir
clinical gel at 37°C over a period of 24 h. Mean TR indices of
these tissue specimens were found to be 77%, 51%, 41%, and
30% of the control (fresh, untreated tissue) value after 2, 6, 9,
and 24 h incubation with the gel, respectively (Figure 7).
Although the TR indices of tissue specimens decreased over
time over 24 h, the tissue viability at 24 h was relatively higher
than that of the deactivated tissue, suggesting that some level
of mitochondrial activity could still be maintained. A 50%
decrease in TR index from control has been used as a limit for
viability [50,51]. Using this cutoff value, tissue specimens
incubated with 1% Tenofovir clinical gel were considered viable
for up to 6 h when maintained at 37 °C.
Measuring Tenofovir Concentrations vs. Depth in
Tissue Using a Transwell Assay
The in vitro Transwell assay was created as a standard
method to evaluate time- and depth-dependent concentration
Figure 4.  Relationships of signal intensity vs.  Tenofovir concentration in fluid, clinical gel, and tissue homogenate.
Serial dilutions of Tenofovir, ranging from 0.01 to 1%w/w, were prepared in alkalinized water (50mM NaOH), gel, and porcine buccal
tissue homogenates. A strong linear dilution response (R2 ≥ 0.99, P <0.05) for concentrations of Tenofovir in solutions, gels, and
tissue homogenates was observed. A saturation effect was not seen at the higher concentrations. This shows that Raman
spectrometry is able to respond linearly to the physiologically relevant concentrations of drug. This linear dependence, in reverse,
shows that Raman spectrometry can be used in practice to deduce the concentration of microbicide from the intensity of Raman
peaks. Also, Tenofovir showed relatively higher signals in clear fluids and gels than in strongly scattering (opaque) tissues. The data
shown represent the mean of 3-4 replicates.
doi: 10.1371/journal.pone.0085124.g004
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distributions within tissue. Figure 8 shows Tenofovir
concentrations vs. time measured in the top fluid compartment,
and within excised porcine buccal tissue specimens that were
incubated in the Transwell assay for varying times ranging from
30 m to 6 h. Tenofovir concentration in tissue increased with
time and peaked at around 6 h. Figure 9 shows the result of a
mass balance computation in which the sum of the amounts of
Tenofovir in tissue and the top layer was subtracted from the
initial amount of Tenofovir. Note the close agreement between
results for this computation and the direct measurements.
Depth-scanning results of Tenofovir distribution from tissue
specimens that were incubated in the Transwell assay for 6 h
showed decreasing peak sizes from the surface down into the
tissue (Figure 10). The intensity of the Tenofovir band at 725
cm-1 with respect to the intensity of the tissue peak at around
643 cm-1 (I725/I643) revealed the relative values of drug
distribution at different depths. Moreover, quantitative analyses
of Tenofovir concentrations showed a decline with depth into
the tissue (Figure 11). These findings suggest that confocal
Raman spectroscopy is able to distinguish different molecular
features and differentiate varying concentrations among
depths.
Strictly speaking, “depth” reported here is the Z-axis
translation of the automated XYZ microscope stage unit. When
confocal Raman is applied to light-scattering matrices, this
"depth" is not identical to the true location of the focal plane
within the sample (see Discussion).
Comparisons of Tenofovir Concentration
Measurements for Raman vs. LC-MS/MS
We validated our Tenofovir measurements by comparison
with ones obtained from the gold standard LC-MS/MS in fluid
and tissue. Figure 12 shows good agreement between the two
methods. They all produced linear regression lines with y-
intercepts of zero, and slopes that did not differ significantly
(ANCOVA, P > 0.05). Figure 13a demonstrates a good linear
correlation between the Tenofovir concentrations obtained from
the two methods. The y-intercepts were not statistically
significantly different from zero (ANOVA, P > 0.05), and the
slopes were not significantly different from one at the 5%
significance level. Figure 13b presents comparisons illustrated
via the Bland-Altman approach for determining the levels of
agreement for concentrations obtained from the two methods
[60]. These results show that across the range of Tenofovir
concentration studied (0.01 to 1.00% w/w), the concentrations
determined by Raman spectroscopy fall within ± 0.08% w/w
(two standard deviations) of the measurements obtained from
the gold standard LC-MS/MS technique.
Discussion
We explored the feasibility of applying confocal Raman
spectroscopy as a useful analytical technique that can
contribute to pharmacokinetic and drug transport analyses. Our
focus was on applications to vaginal delivery of topical anti-HIV
Figure 5.  Calibration sensitivity for detection of Tenofovir, IQP-0528 and Dapivirine in fluid, clinical gel and tissue.  The
slopes, i.e. the incremental changes in intensity per change in concentration, of the linear dilution response curves represent the
sensitivities of measurement. Response differences were observed for the three drugs in the different matrices. A significant
difference in sensitivities among the drugs was observed (P<0.0001, two-way ANOVA with Fisher’s PLSD), and these relative
sensitivities of drugs were dependent on the matrix in which they were measured (drug*matrix interaction, P <0.01). Fluids gave
higher sensitivities than other matrices due to less background scattering. Dapivirine tended to have higher sensitivity than other
microbicide drugs. The data shown represent the mean ± standard error of 3-4 replicates.
doi: 10.1371/journal.pone.0085124.g005
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drugs. The Raman technique was applied to characterize three
current microbicide drugs and to measure their concentrations
in fluids, clinical gels, and excised tissue specimens. Here, we
utilized methods of tissue and drug preparation common in the
microbicides field, and in others where drug permeability in
tissue is evaluated, as well. Tissue fine structure in such
specimens in vitro may not be identical to that of intact tissue in
vivo, and this could alter drug transit rates. In this regard, the
confocal Raman spectroscopic technique could be used in
quantitative evaluation of how details of tissue harvesting and
preparation affect such drug transit rates. Indeed the direct
depth-dependent measurements with the Raman based
technique could well be more precise than traditional
Figure 6.  Chemical structures of Tenofovir, IQP-0528, and Dapivirine.  
doi: 10.1371/journal.pone.0085124.g006
Table 5. Limit of detection (LOD) with the Horiba Raman system for Tenofovir, IQP-0528 and Dapivirine in different media.
Drugs Media LOD (%w/w)
Tenofovir Water 0.01
 Gel 0.02
 Porcine tissue homogenate 0.04
IQP-0528 Ethanol 0.01
 Gel 0.03
 Porcine tissue homogenate 0.04
Dapivirine 70/30 iprOH/water 0.003
 Gel 0.006
 Porcine tissue homogenate 0.006
doi: 10.1371/journal.pone.0085124.t005
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approaches that rely upon physical sectioning of tissue
specimens.
Due to its highly chemically-specific nature, Raman
spectroscopy was able to distinguish all the microbicide drugs
from an optically scattering and absorbing tissue, which is itself
a heterogeneous mixture of molecules and supramolecular
structures. In fact, a high level of optical similarity between
Raman spectral backgrounds of human tissue and porcine
tissue has been observed [47-49], suggesting a similar
biochemical composition of the two tissues. We also observed
a strong linear dependence of the Raman peak intensities over
ranges of microbicide concentrations in the three types of
media. The linear dependence of Raman peak intensity on the
number of molecules involved in the scattering process per unit
volume is well established [61]. This renders Raman
spectroscopy a useful technique for gaining both qualitative
and quantitative information about the molecular and structural
composition of a sample. Further, it motivates the use of
Raman for quantitative measurements of concentrations of
molecules.
Our emphasis was on Tenofovir. This is the microbicide drug
that has received the greatest study to date and, pending
results of the current FACTS 001 clinical trial, could be the first
anti-HIV microbicide approved for vaginal application. We
found a spectroscopic distinction between Tenofovir and
Tenofovir diphosphate, the bioactive form of Tenofovir, which is
phosphorylated from Tenofovir after it enters CD4+cells or
macrophages. It is likely, however, that the actual Tenofovir
diphosphate levels in mucosal tissue after in vivo Tenofovir
administration would be too low to be detectable using Raman
spectroscopy. For example, it was found that Tenofovir
diphosphate concentrations in vaginal biopsies were only about
5-8% of the Tenofovir concentrations [36,58,62]. However, the
level of local Tenofovir diphosphate can be objectively
estimated from the local Tenofovir concentration, since there
appears to be a linear correlation between the levels of the two
forms of Tenofovir present in tissue [63]. This relationship could
help in estimating the local Tenofovir diphosphate
concentration in tissue from the spectroscopically measured
Tenofovir concentration using Raman spectroscopy.
We validated our Tenofovir measurements with gold
standard ones obtained using an LC-MS/MS method validated
according to FDA criteria [16,64] in fluid and tissue samples.
Good linear relationships between two methods over a range of
Tenofovir concentrations were demonstrated. Measured
concentration values were tightly scattered about statistically
significant linear regression lines that passed through the
origin.
We implemented a standardized Transwell assay as an in
vitro model system to quantify drug permeation into and
Figure 7.  MTT assay of porcine tissue specimens fully submerged in 1% Tenofovir clinical gel at 37 °C.  Freshly excised
tissue specimens were incubated while fully submerged in 1% Tenofovir gel and maintained at 5% CO2 and 37 °C for different
amounts of time. After incubation, the tissue specimens were removed from the gel, washed five times, and subjected to the MTT
assay. Results were computed as a tetrazolium reductase index (TR index; absorbance per mg tissue) by dividing the absorbance
the formazan product at 570 nm by the dry weight of the tissue specimen. Control samples were fresh untreated tissue specimens
(1.6 h post mortem). To obtain deactivated (dead) samples, tissue specimens were boiled in water for 2h to inactivate enzyme
activity. Data shown represent mean ±SE of 3-4 replicates.
doi: 10.1371/journal.pone.0085124.g007
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through tissue specimens. In our initial application here, the
assay was constructed with a drug-loaded liquid layer over the
tissue. However, this configuration can be extended to apply a
gel layer of defined thickness over the tissue; our group has
experience in creating such layers in Transwell assays
involving HIV migration rates [65]. The approach to drug
transport here is more informative than traditional permeability
assays [66] in that it quantifies concentration in the tissue as a
function of time during the course of an experiment. The
Raman-transwell approach also shows promise as a means of
measuring the local concentrations of Tenofovir at different
depths as it permeates into and through tissue specimens. In
fact, our z-scans in the Transwell experiments detected
Tenofovir to a depth of 200+ µm (see next paragraph). Such
information on drug concentration distributions could then be
processed to compute values of drug diffusion and partition
coefficients, which are fundamental transport parameters that
govern the process of drug release from a gel and transport
into and through the tissue [13,67]. These parameters can be
used in predictive computations, using compartmental models,
of microbicide pharmacokinetics, that can aid the
understanding of the mechanisms of microbicide drug delivery
and, thus, be used in product design and evaluation [18].
As noted earlier, a major challenge in confocal Raman
spectroscopy, especially when working with complex biological
tissues, is to accurately determine the depth resolution and the
penetration depth [68-72]. Highly scattering or turbid materials
such as biological tissue have spatially inhomogeneous
refractive indices that contribute to local uncertainties in depth
profiling. A conventional microscope illuminates the focus with
a cone of light whose rays travel through many paths through
the matrix to reach the focal point. This averages
inhomogeneities in the matrix to some extent. In contrast, the
type of confocal microscope used here has a single laser beam
for illumination that may be only 100 microns in diameter,
smaller than the sizes of some of the inhomogeneities. This
beam has a single path through the matrix which can deviate
significantly from a straight path, and it does not have the
benefit of averaging.
This topic has been explored in the literature. For example
when testing confocal Raman imaging, using multilayered
polymeric film systems with refractive indices similar to those of
human skin, Xiao et al found that the penetration depth was
underestimated by 15-20% due to the combination of scattering
and refractive index layers [71]. However, as was shown in
later studies [72], the local depth uncertainty is dependent upon
the optical elements in the system and the refractive index of
the material, which may vary amongst experiments. Notably,
several mathematical models have been developed to simulate
the laser beam distortions induced by refractive layers and light
Figure 8.  Tenofovir concentrations vs.  time in tissue and the top fluid compartment in the Transwell assay.
Transwell assay experiments were performed to characterize the transport of Tenofovir into and through tissue after microbicide
application. The Transwell setup was maintained at 37°C and 5% CO2 in a Heracell incubator for different amounts of time, ranging
from 30 min to 6 h. After incubation, the tissue (7-mm diameter, 1-mm thickness) and fluids were isolated and stored at −80°C.
Thawed tissue specimens and fluids were scanned. Quantification of Tenofovir concentrations was performed by interpolation,
referencing to calibration curves of Tenofovir in tissue homogenates and fluids (shown in Figure 4). Each data point gives the
median, and the smallest and largest measurements in the 3 independent experiments (n=3).
doi: 10.1371/journal.pone.0085124.g008
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scattering effects in order to better estimate the depth and the
resolution values [69,70,73]. However, these models tended to
overestimate the depth when focusing deeper into the skin and,
as noted by Tyali et al [72], all of these estimations are still “far
from representing an accurate estimation” of the real depth
value. Clearly, further work is required to evaluate local
uncertainties in depth profiling in confocal Raman
measurements on light-scattering tissues. Follow up
investigation of this issue is currently underway in our
laboratory.
A key to practical use of Raman is whether it achieves both
sufficient sensitivity and specificity for a particular application.
The target sensitivity will depend on the concentrations of drug
in the matrix of interest. For vaginal microbicides this would, for
example, be maximum concentration in the delivery vehicle
and much lower concentration in vaginal mucosal tissue
harvested after in vivo dosing. In the evaluation of topical
microbicides, confocal Raman spectroscopy could in principle
perform several types of measurements, including: (1) drug
release from test vehicles into tissue specimens; (2) drug
permeation into and through tissue specimens; and (3) drug
concentrations in specimens collected from pharmacokinetic
studies. Clearly, drug concentrations in (3) would be lower than
those encountered in in vitro experiments for (1) and (2), and
this would necessitate a greater sensitivity. The three
microbicide drugs studied here are believed to have different
potencies in their anti-HIV activities, and their current loaded
concentrations in clinical vaginal gels are consequently
different. The standard concentration for Tenofovir in its clinical
vaginal gel is 1% w/w. Its average concentration in human
vaginal biopsy specimens has been about 0.01% w/w
[36,58,62]. Prototype candidate clinical Dapivirine gels have
been formulated with concentrations of 0.001, 0.005, 0.02, and
0.05% w/w [14,37]. A silicone matrix vaginal ring now in Phase
3 trials is loaded with 25 mg of Dapivirine, corresponding to a
net concentration of about 0.31%w/w [39,40]. Dapivirine
concentrations in human vaginal tissue biopsies for the gel
trials were 0.0001- 0.0356%w/w. Mean Dapivirine
concentration in human vaginal biopsy specimens in two phase
I trials of intravaginal rings (IPM 001 and IPM 008) was in the
range of 0.00003-0.00035%w/w. IQP-0528 has been
formulated at a concentration of 0.25% in a gel [13], but no
clinical trials of this gel have yet been conducted. More
recently, a combination gel has been formulated and initially
evaluated in vitro; this contains 2.5% Tenofovir and 1%
IQP-0528 [12]. These various drug concentrations can be
compared to the limits of detection (LOD) in the current study
(Table 5). For Tenofovir, the LOD is about 25 - 100 fold lower
than the concentration in the gel. The LOD for Dapivirine is
about 8 - 17 fold lower than the concentration in the standard
(0.05%) gel candidate. It is approximately 52 - 103 fold lower
than the net concentration in the ring. The LOD for IQP-0528 is
Figure 9.  Tenofovir concentrations (measured vs. computed) in the bottom fluid compartment in the Transwell assay.  A
mass balance computation calculated the difference between the initial amount of Tenofovir in the fluid overlayer and the
subsequent time-dependent sum of the total amounts of drug in the top layer and tissue. The good agreement between this mass
balance prediction and the actual values measured supports the accuracy of the measurements. The box-and-whisker plot shows
smallest value (lower bar), lower quartile (bottom of box), median (line through box), upper quartile (top of box), and largest
observation (upper bar). The concentrations in the bottom fluid compartment from 0 to 9 h were not measurable (i.e., they were
below the lower detection limit of the Raman quantification).
doi: 10.1371/journal.pone.0085124.g009
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6 - 25 fold lower than the current concentration formulated in
the gel. Consequently, the current Raman configuration could
be used for in vitro analyses of drug release from current
microbicide vehicles (gels and rings) and for tissue permeation
studies.
The LOD for Tenofovir in current Raman set up here is about
4X higher than the concentration in the in vivo biopsy data for
the 1% Tenofovir gel in clinical trials. However, we note that the
LOD of Tenofovir in tissue is comparable to or lower than
computational predictions (from a compartmental PK model) of
Tenofovir concentrations in epithelium and upper stroma [18].
That is, to the extent that drug distributions in tissue follow
diffusion theory, the time dependent concentrations of
Tenofovir in upper layers may be much higher than average
values determined from tissue biopsy punches. If so, then
confocal Raman might be useful to measure Tenofovir
concentrations in the upper mucosal layers of biopsy
specimens. For Dapivirine, the LOD in tissue is from 6-fold
lower to >17-fold higher than the concentrations measured in
vaginal biopsies for the clinical trials. Moreover, the sensitivity
of the Raman measurements of Tenofovir with the current
instrument was sufficient to quantify concentration down to a
depth of 200+ µm, and data of this kind could then be used in
initial analyses of drug concentration distributions down into
harvested vaginal mucosal tissues.
Clearly, improvements are needed in the sensitivity of
Raman-based measurements of microbicide drugs. The
quantitative detection of compounds in complex,
heterogeneous biological matrices, such as tissue, is generally
confounded by the optical effects of out-of-focus light scattering
and absorption. A key feature of the confocal approach is use
of spatial filtering to reject the out-of-focus light from
neighboring focal planes, by illuminating only one spot in a
plane of focus through a pinhole. Implementation of confocal
Raman imaging thus provides an improvement in axial
resolution. In the current study, however, there was a trade-off
between reasonable scanning times and achievable sensitivity
of measurement. For Tenofovir, an integration time as low as
30 seconds was generally sufficient to measure high
concentrations in tissue (> 0.1 %), while a scanning time as
long as 5 minutes was required for detection near the LOD.
Further improvements in the detection sensitivity would enable
measurements of lower concentrations with reasonable
Figure 10.  Z-scanning Raman spectra for Tenofovir penetrating excised tissue in the Transwell assay.  7 porcine buccal
tissue specimens were incubated under an isotonic solution of 1% Tenofovir in PBS for 6 h in the Transwell assay. After incubation,
the tissue was stored at −80°C overnight to stop the drug permeation process. Thawed tissue specimens were subjected to
confocal Raman scans at different depths beneath the tissue surface to quantify Tenofovir distribution within the tissue specimens.
The Raman spectra were acquired at different z-axis depths using a Horiba Xplora confocal Raman microscope with an excitation
wavelength of 785 nm and an Olympus 50x long-working distance objective lens (N.A. =0.5). The acquisition time was 240 s for
each spectrum. All spectra were normalized with respect to the tissue Raman band at 643 cm-1 and offset vertically for clarity of
presentation.
doi: 10.1371/journal.pone.0085124.g010
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scanning times, and would increase the depth down into tissue
at which measurements could be made.
In summary, we have presented an initial technical
evaluation of the feasibility of applying Raman spectroscopy
not only for qualitative identification, but also for quantitative
analysis of local microbicide drug concentrations in fluids,
clinical drug delivery gels and tissues. Results suggest that
Raman offers promise for such applications. These can include
analyses of biopsy specimens from in vivo PK studies, and
measurements of drug transport in vitro from vehicles and
fluids into excised tissue specimens. Implementation of
confocal Raman spectroscopy improved the fidelity of z-axis
measurements versus Raman as applied in a non-confocal
configuration. Thus, the confocal Raman approach is the
preferred modality in future studies of the kind here. Further,
the Transwell configuration implemented here offers promise
for measurement of concentrations and concentration profiles
that can enable computation of traditional measures of drug
release from vehicles and tissue permeability, and also
computation of fundamental and incisive transport parameters
– drug diffusion and partition coefficients in both target tissues
and drug delivery vehicles. Such information can contribute to
improved microbicide product design and evaluation.
Figure 11.  Tenofovir concentration vs.  depth in tissue in the
Transwell assay.
Confocal Raman scans were performed on tissue specimens that had been incubated under a fluid layer (containing 1% Tenofovir)
in the Transwell assay for 6 h (Figure 10). After baseline correction, the intensity of the Tenofovir Raman band was normalized with
respect to the intensity of the tissue band at 643 cm-1. Normalized intensities were background-subtracted and fitted into a
respective calibration curve of Tenofovir in tissue homogenate to deduce the concentration vs. depth profiles. The Raman
measurements showed a decline in concentration as the depth into the tissue increased. Data shown give mean ± standard error of
the mean (n=7).
doi: 10.1371/journal.pone.0085124.g011
Confocal Raman Spectroscopy of Microbicides
PLOS ONE | www.plosone.org 18 December 2013 | Volume 8 | Issue 12 | e85124
Figure 12.  Comparative measurement of Tenofovir concentration using Raman vs.  LC-MS/MS in solution and tissue.
Freshly excised porcine buccal tissue specimens were incubated in serially diluted concentrations of Tenofovir in Ringer's solution
and allowed to equilibrate for 24 h. After incubation, the tissue specimens and the surrounding fluid were collected and stored at
−80°C overnight for analysis by both techniques: (a) The initial serially-diluted concentrations of Tenofovir in Ringer's solution
measured by both techniques were plotted against its known concentrations in solution. These two techniques produced slopes that
did not differ significantly (ANCOVA, P > 0.05); (b) the final concentrations of Tenofovir within tissue specimens measured by both
techniques were plotted against concentrations of Tenofovir solution in equilibrium with tissue. ANCOVA also showed that the
slopes obtained by both techniques were not significantly different (P > 0.05).
doi: 10.1371/journal.pone.0085124.g012
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Figure 13.  Agreement of Raman measurements of Tenofovir Concentration (Horiba instrument) with gold-
standard.  measurements by LC-MS/MS.
Serial dilutions of Tenofovir in Ringer's solution were equilibrated with freshly excised tissue specimens for 24 h at 4 °C. The
Tenofovir concentration in fluid before (initial) and after (final) incubation, and the final concentration in tissue, were evaluated by
both techniques: (a) the correlations between Tenofovir concentration values in fluid and tissue obtained from the Raman
spectroscopic method vs. those derived from the validated LC-MS/MS technique. The dashed line indicates a straight 45-degree
line (y=x) passing through the origin of the axes. (b) Bland-Altman analysis for determining the levels of agreement between the two
measurement methods of Tenofovir concentrations in fluid and tissue. This gives absolute differences between the two
measurement methods in relation to their average values. Solid lines represent mean differences, and dashed lines indicate the
95% confidence intervals.
doi: 10.1371/journal.pone.0085124.g013
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